Gayatri BioOrganics Ltd

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Gayatri BioOrganics Limited, a micro-cap commodity chemicals company with a market capitalisation of ₹117.00 crores, reported a quarterly loss of ₹0.42 crores for Q4 FY26 (Mar'26), marking a significant deterioration from the ₹0.17 crore loss recorded in Q4 FY25. The company's shares have tumbled 4.99% following the results announcement, trading at ₹14.08 as investor sentiment remains deeply negative towards this structurally challenged enterprise that has generated zero revenue for seven consecutive quarters.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Surging from a 52-week low of Rs 6.13 to a fresh high of Rs 20, Gayatri BioOrganics Ltd has delivered an impressive 182.45% return over the past year, significantly outperforming the Sensex which declined by 4.09% during the same period. This milestone reflects a powerful technical momentum that has propelled the stock well above its key moving averages.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 05 May 2025, but the analysis below reflects the stock's current position as of 03 March 2026, incorporating the latest fundamentals, returns, and financial metrics.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Gayatri BioOrganics Limited, a micro-cap commodity chemicals company with a market capitalisation of ₹106.00 crores, reported another quarter of complete operational shutdown in Q3 FY26 (October-December 2025), posting zero revenue and a net loss of ₹0.22 crores. The company's stock, trading at ₹14.28, remains trapped in a prolonged crisis that has seen no commercial activity for over seven consecutive quarters, raising serious questions about its viability as a going concern.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Gayatri BioOrganics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.